Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer

Fig. 5

The expression of RXFP4 in human colorectal cancer and Kaplan–Meier survival curve analysis for INSL5/RXFP4 expression in colorectal cancer. a Expression of RXFP4 is reduced in colorectal cancer (***, P < 0.001). b High RXFP4 expression has better prognosis compared with low-RXFP4 group (P = 0.011). c Kaplan–Meier survival curve of INSL5/RXFP4 expression in colorectal cancer patients

Back to article page